AGENT
AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
AGENT
Industry:
Biotechnology Health Care Health Diagnostics Life Science Neuroscience
Founded:
2018-03-16
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.agent-biotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
491 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag IPv6 Google Apps For Business
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Current Employees Featured
Founder
Investors List
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - AgenT
Bernard Majoie
Bernard Majoie investment in Pre Seed Round - AgenT
Official Site Inspections
http://www.agent-biotech.com
- Host name: 217-160-0-51.elastic-ssl.ui-r.com
- IP address: 217.160.0.51
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "AgenT"
AgenT - Detecting Alzheimer's Early, When It Could Be prevented
At AgenT we're developing the first blood diagnosis to detect Alzheimer's patients up to 20 years before the irreversible symptoms. Today, when we detect the disease with the current …See details»
AgenT - Crunchbase Company Profile & Funding
AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, …See details»
AgenT Company Profile 2024: Valuation, Funding & Investors
Sep 25, 2024 AgenT General Information Description. Developer of a multi-omics platform designed to detect Alzheimer's disease at its earliest stages in patients. The company's …See details»
AgenT - LinkedIn
AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, …See details»
AgenT - healthtechinnovationdays6.com
AgenT is a French life sciences company on a mission to defeat Alzheimer’s by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, …See details»
AgenT SAS - Overview, News & Similar companies | ZoomInfo.com
AgenT SAS contact info: Phone number: +33 666439061 Website: www.agent-biotech.com What does AgenT SAS do? AgenT is developing a multiomics blood test to detect Alzheimer's early …See details»
AgenT - Company Profile - Tracxn
Oct 22, 2024 AgenT - Developer of AI-based blood diagnosis solutions to detect Alzheimer’s diseases. Raised funding over 1 round from 2 investors. Founded by Jerome Braudeau and …See details»
AgenT | Paris, France Startup
AgenT is a French biotech developing the first blood diagnosis to detect Alzheimer's up to 20 years before the onset of the irreversible symptoms. Only company supported by France Alzheimer, AgenT has combined 10 years of …See details»
AgenT Company Profile - Office Locations, Competitors, Revenue …
AgenT has 5 employees across 2 locations and $490.77 k in total funding,. See insights on AgenT including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
AgenT - Drug pipelines, Patents, Clinical trials - Synapse
Explore AgenT with its drug pipeline, therapeutic area, technology platform, 11 news.See details»
AgenT - Meet Our Team - agent-biotech.com
We have assembled a team of experienced scientists, industry pioneers and accomplished company builders who are passionate about changing the outlook of a Alzheimer's diagnosis. Interested in joining our team? Apply hereSee details»
AgenT company information, funding & investors | EIT Health …
AgenT. Developing the first blood diagnosis to detect Alzheimer’s disease while it’s still in the silent phase. Learn more. Launch date. Mar 2018. Employees. 11-50 people. Market cap …See details»
AgenT - Partners
AgenT is working with research institutes, pharmaceutical companies, and leading multiomics companies to develop the first blood diagnosis of the silent phase of Alzheimer's. Learn more …See details»
AgenT-Biotech - F6S
About AgenT-Biotech AgenT is a life sciences company whose mission is to defeat Alzheimer’s by targeting the silent phase. By combining multi-omics assays with advanced machine learning …See details»
AgenT - French Healthcare Corner JP Morgan Week
Agent-biotech.com. Who are we ? AgenT, a life sciences company, is dedicated to combatting Alzheimer’s disease by focusing on its silent phase. The challenge lies in identifying the …See details»
About AgenT-Biotech - Medium
Read more about AgenT-Biotech. AgenT is developing the first blood diagnosis to detect Alzheimer’s up to 20 years before the onset of the irreversible symptoms.See details»
AgenT - One of the Largest Multiomics Studies on Alzheimer's
In order to enable the most accurate early detection of Alzheimer's, AgenT is conducting what we believe to be one of the largest multiomics clinical study ever pursued in Alzheimer's research.See details»
Two Biotech CEOs Convicted in Securities Fraud Scheme | FDA
Dec 10, 2024 Pourhassan was the chief executive officer of CytoDyn, and Kazempour was the chief executive officer of Amarex Clinical Research LLC, a Germantown, Maryland-based …See details»
How to Become a Biotechnology Patent Agent (Guide to Genetic …
Step 12: Stay Informed on Biotech Innovations and Patent Law Updates. As a Biotechnology Patent Agent, it is absolutely crucial to remain current on the most recent advancements in …See details»
AgenT - How Medical AI Can Lead to an Early Detection of …
AgenT uses multiomics and AI to detect Alzheimer's early through a simple blood test. See how AgenT’s multiomics platform can lead to early detection of Alzheimer's. SCIENCESee details»